Chinese Journal of Viral Diseases最新文献

筛选
英文 中文
Research progress on the clinical application of lopinavir/ritonavir for the treatment of coronavirus infection 治疗冠状病毒感染的洛匹那韦/利托那韦临床应用研究进展
Chinese Journal of Viral Diseases Pub Date : 1900-01-01 DOI: 10.16505/j.2095-0136.2021.0001
Ye Pu
{"title":"Research progress on the clinical application of lopinavir/ritonavir for the treatment of coronavirus infection","authors":"Ye Pu","doi":"10.16505/j.2095-0136.2021.0001","DOIUrl":"https://doi.org/10.16505/j.2095-0136.2021.0001","url":null,"abstract":"In the face of the sudden outbreak of novel coronavirus pneumonia (coronavirusdisease-19, COVID-19), the research and development of new antiviral drugs requires a certain amount of time and cost, and it is urgent to find safe and effective antiviral drugs that can be used clinically. Lopinavir/ritonavir (lopinavir/ritonavir, LPV/r) is a commonly used antiviral drug against adult or child human immunodeficiency virus (humanimmunodeficiency, HIV) infections. Past animal trials and clinical experience suggest It is expected to have a certain anti-viral efficacy against the new coronavirus in the fight against severe acute respiratory syndrome (Severe acute respiratory syndrome, SARS) and Middle East respiratory syndrome (Midle East respiratory syndrome, MERS). drug. Especially for patients with mild infections, the combination of drugs seems to be expected to exert a better effect, but it is necessary to pay attention to the issue of drug safety and use drugs with caution. This article aims to review the clinical research progress of LPV/r anti-coronavirus infection treatment for clinical reference.","PeriodicalId":380988,"journal":{"name":"Chinese Journal of Viral Diseases","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127150557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical analysis of 71 COVID-19 death cases in Wuhan 武汉市71例新冠肺炎死亡病例临床分析
Chinese Journal of Viral Diseases Pub Date : 1900-01-01 DOI: 10.16505/j.2095-0136.2021.0005
Chaoe Zhou
{"title":"Clinical analysis of 71 COVID-19 death cases in Wuhan","authors":"Chaoe Zhou","doi":"10.16505/j.2095-0136.2021.0005","DOIUrl":"https://doi.org/10.16505/j.2095-0136.2021.0005","url":null,"abstract":"Objective To study the factors influencing the death of the novel coronavirus disease 2019 (COVID-19) patients in Wuhan city of China. Methods The clinical data of 71 COVID-19 death cases admitted and treated in the Third Hospital of Wuhan were retrospectively analyzed. and SPSS 22.0 software was used for statistical analysis to compare the laboratory results in different periods of the disease. Results Males (64.79%. 46/71) accounted for a large proportion of the 71 cases of COVID-19 deaths in Wuhan city of China. The median age was 70.0 years old. 81.69% (58/71) were over 60 years old. People with underlying diseases accounted for 76.06% (54/71). the most common underlying disease was hypertension (53.52%. 38/71). and the most common clinical symptom was fever (85.91%. 61/71). The majority of the patients were severe type (56.34%. 40/71) at the time when they were admitted to the hospital. According to the laboratory results. their lactate dehydrogenase (LDH) [469.50 (454.50~552.75) U/L], blood glucose [9.95 (6.83~13.95) mmol/L] at the end stage were higher than that at admission with LDH [144.00 (123.75~273.25) U/L] and blood glucose [6.60 (5.20~10.70) mmol/L] (Z= -3.298, -2.542, both P < 0.05). Blood gas analysis at the end stage showed that their pH value [7.31 (7.27~7.34)]. oxygen partial pressure (PaO2) [45.00 (35.00~56.00) mm Hg] were lower than that at admission with the pH value [7.38 (7.34~7.41)] and PaO2 [82.50 (77.50~88.50) mm Meanwhile. their partial pressure of carbon dioxide (PaCO2) [59.00 (48.75~60.75) mm Hg] was higher than that at admission [42.00 (37.25~48.75) mm Hg] (Z= -2.906. -3.296. -3.206. all P < 0.05). Conclusions Elder age and combined underlying diseases account for a higher proportion of deaths. Lung injury. hypoxemia. myocardial injury, and abnormal glucose metabolism caused by the disease are the major causes of death in COVID-19 patients in Wuhan city of China.","PeriodicalId":380988,"journal":{"name":"Chinese Journal of Viral Diseases","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128115047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信